Stokes Frank sold $742K of CSTL
Stokes Frank (Chief Financial Officer) sold 24,908 shares of CASTLE BIOSCIENCES INC (CSTL) at $29.77 ($0.74M total) on 2026-08-14.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed open-market sale by the CFO, including share count, price, and post-transaction holdings.
Market read
Traders may briefly reassess sentiment around insider behavior, but there is no new business or financial performance information.
What to watch
No 10b5-1 plan is cited, but the filing lacks context on taxes, diversification needs, or pre-existing compensation schedules.
Background
The article is an SEC Form 4 insider transaction disclosure for CASTLE BIOSCIENCES (CSTL).
Ticker impact
SEC Form 4 shows CFO Stokes Frank sold 24,908 shares of CSTL for about $741.5K at $29.77 on 2026-08-14.
Low likelihood of a sustained price move; any reaction is likely limited to near-term sentiment.
The filing is a primary disclosure of an insider transaction, but the article provides no accompanying earnings, guidance, or operational change.
Market effects
Minimal, as this is a single-company insider sale with no sector-wide regulatory or operational signal.
None indicated.
None indicated.
Counterpoint
The sale may be routine liquidity management and does not necessarily reflect negative views on CASTLE BIOSCIENCES fundamentals.
Key entities
- issuerCASTLE BIOSCIENCES INC
Company whose insider transaction is disclosed via SEC Form 4.
- insiderStokes Frank
Chief Financial Officer who sold shares in an open-market transaction.
